About Nephroblastoma
Nephroblastoma is a rare disease catalogued by Orphanet (ORPHA:654). It is associated with the BRCA2, GPC3, CTR9 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Nephroblastoma trials.
Search ClinicalTrials.gov for "Nephroblastoma" or filter by Orphanet code ORPHA:654 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Nephroblastoma trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Nephroblastoma. Updated daily.